HEADER HYDROLASE/HYDROLASE INHIBITOR 13-JUL-16 5KU9 TITLE CRYSTAL STRUCTURE OF MCL1 WITH COMPOUND 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN COMPND 6 EAT/MCL1,MCL1/EAT; COMPND 7 EC: 3.6.1.11; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: MOUSE, HUMAN; SOURCE 4 ORGANISM_TAXID: 10090, 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.D.FERGUSON REVDAT 4 04-OCT-23 5KU9 1 REMARK REVDAT 3 31-JAN-18 5KU9 1 TITLE REVDAT 2 01-MAR-17 5KU9 1 JRNL REVDAT 1 11-JAN-17 5KU9 0 JRNL AUTH J.W.JOHANNES,S.BATES,C.BEIGIE,M.A.BELMONTE,J.BREEN,S.CAO, JRNL AUTH 2 P.A.CENTRELLA,M.A.CLARK,J.W.CUOZZO,C.E.DUMELIN,A.D.FERGUSON, JRNL AUTH 3 S.HABESHIAN,D.HARGREAVES,C.JOUBRAN,S.KAZMIRSKI,A.D.KEEFE, JRNL AUTH 4 M.L.LAMB,H.LAN,Y.LI,H.MA,S.MLYNARSKI,M.J.PACKER,P.B.RAWLINS, JRNL AUTH 5 D.W.ROBBINS,H.SHEN,E.A.SIGEL,H.H.SOUTTER,N.SU,D.M.TROAST, JRNL AUTH 6 H.WANG,K.F.WICKSON,C.WU,Y.ZHANG,Q.ZHAO,X.ZHENG,A.W.HIRD JRNL TITL STRUCTURE BASED DESIGN OF NON-NATURAL PEPTIDIC MACROCYCLIC JRNL TITL 2 MCL-1 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 8 239 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28197319 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00464 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 15275 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 775 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.96 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2776 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2280 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2660 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.18 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 116 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2311 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 91 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.98220 REMARK 3 B22 (A**2) : 0.01740 REMARK 3 B33 (A**2) : 6.96480 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.20260 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.274 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.209 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.281 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.214 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2444 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3288 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 913 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 60 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 401 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2444 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 304 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2937 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.52 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.91 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -0.5999 -18.9233 19.1375 REMARK 3 T TENSOR REMARK 3 T11: -0.1326 T22: -0.1979 REMARK 3 T33: -0.1731 T12: 0.0600 REMARK 3 T13: 0.0439 T23: -0.0324 REMARK 3 L TENSOR REMARK 3 L11: 3.4118 L22: 3.3200 REMARK 3 L33: 3.6792 L12: -0.7833 REMARK 3 L13: 1.1414 L23: -0.5857 REMARK 3 S TENSOR REMARK 3 S11: 0.0661 S12: 0.2293 S13: -0.1127 REMARK 3 S21: -0.0943 S22: -0.1393 S23: -0.0037 REMARK 3 S31: -0.2357 S32: -0.0726 S33: 0.0733 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -28.2510 -14.0082 5.1637 REMARK 3 T TENSOR REMARK 3 T11: -0.2314 T22: 0.2548 REMARK 3 T33: -0.1040 T12: 0.2392 REMARK 3 T13: 0.1497 T23: -0.0348 REMARK 3 L TENSOR REMARK 3 L11: 9.6117 L22: 5.3907 REMARK 3 L33: 5.7050 L12: -2.8253 REMARK 3 L13: -3.6130 L23: -1.4905 REMARK 3 S TENSOR REMARK 3 S11: -0.3858 S12: 0.2250 S13: -1.4066 REMARK 3 S21: -0.2452 S22: -0.3233 S23: 0.5139 REMARK 3 S31: 0.3701 S32: -0.5272 S33: 0.7092 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KU9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000222760. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15285 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 44.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.20200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 9.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4G35 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.1 M TRIS, PH 8, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 42.19050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.32350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 42.19050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.32350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 166 REMARK 465 PRO A 167 REMARK 465 LEU A 168 REMARK 465 GLY A 169 REMARK 465 SER A 170 REMARK 465 GLU A 171 REMARK 465 ASP A 195 REMARK 465 SER A 196 REMARK 465 ASP A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 GLY A 326 REMARK 465 GLY A 327 REMARK 465 GLY B 166 REMARK 465 PRO B 167 REMARK 465 LEU B 168 REMARK 465 GLY B 169 REMARK 465 SER B 170 REMARK 465 GLU B 171 REMARK 465 ASP B 172 REMARK 465 SER B 193 REMARK 465 LYS B 194 REMARK 465 ASP B 195 REMARK 465 SER B 196 REMARK 465 LYS B 197 REMARK 465 PRO B 198 REMARK 465 LEU B 199 REMARK 465 GLY B 200 REMARK 465 GLU B 201 REMARK 465 ALA B 202 REMARK 465 GLY B 203 REMARK 465 ALA B 204 REMARK 465 ALA B 205 REMARK 465 GLY B 206 REMARK 465 ASP B 323 REMARK 465 LEU B 324 REMARK 465 GLU B 325 REMARK 465 GLY B 326 REMARK 465 GLY B 327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 236 -75.83 -76.06 REMARK 500 ILE B 237 73.76 51.35 REMARK 500 LYS B 302 43.34 -108.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 240 OE1 REMARK 620 2 GLN A 283 OE1 56.0 REMARK 620 3 SER A 285 OG 73.2 24.8 REMARK 620 4 HOH A 542 O 138.8 127.3 102.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6XJ A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6XJ B 401 DBREF 5KU9 A 166 327 PDB 5KU9 5KU9 166 327 DBREF 5KU9 B 166 327 PDB 5KU9 5KU9 166 327 SEQRES 1 A 162 GLY PRO LEU GLY SER GLU ASP ASP LEU TYR ARG GLN SER SEQRES 2 A 162 LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN ALA THR SEQRES 3 A 162 GLY SER LYS ASP SER LYS PRO LEU GLY GLU ALA GLY ALA SEQRES 4 A 162 ALA GLY ARG ARG ALA LEU GLU THR LEU ARG ARG VAL GLY SEQRES 5 A 162 ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE GLN GLY SEQRES 6 A 162 MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP ASP VAL SEQRES 7 A 162 LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SER ASP SEQRES 8 A 162 GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU ILE SER SEQRES 9 A 162 PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR ILE ASN SEQRES 10 A 162 GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER ILE THR SEQRES 11 A 162 ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU VAL LYS SEQRES 12 A 162 GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE HIS VAL SEQRES 13 A 162 GLU ASP LEU GLU GLY GLY SEQRES 1 B 162 GLY PRO LEU GLY SER GLU ASP ASP LEU TYR ARG GLN SER SEQRES 2 B 162 LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN ALA THR SEQRES 3 B 162 GLY SER LYS ASP SER LYS PRO LEU GLY GLU ALA GLY ALA SEQRES 4 B 162 ALA GLY ARG ARG ALA LEU GLU THR LEU ARG ARG VAL GLY SEQRES 5 B 162 ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE GLN GLY SEQRES 6 B 162 MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP ASP VAL SEQRES 7 B 162 LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SER ASP SEQRES 8 B 162 GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU ILE SER SEQRES 9 B 162 PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR ILE ASN SEQRES 10 B 162 GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER ILE THR SEQRES 11 B 162 ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU VAL LYS SEQRES 12 B 162 GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE HIS VAL SEQRES 13 B 162 GLU ASP LEU GLU GLY GLY HET NA A 401 1 HET 6XJ A 402 45 HET 6XJ B 401 45 HETNAM NA SODIUM ION HETNAM 6XJ (3~{S})-3-AZANYL-4-(4-BROMOPHENYL)-~{N}-[(3~{S})-1-[2- HETNAM 2 6XJ [[(2~{R})-1-(3,4-DICHLOROPHENYL)-4-(METHYLAMINO)-4- HETNAM 3 6XJ OXIDANYLIDENE-BUTAN-2-YL]AMINO]-2-OXIDANYLIDENE- HETNAM 4 6XJ ETHYL]-2-OXIDANYLIDENE-4,5-DIHYDRO-3~{H}-1-BENZAZEPIN- HETNAM 5 6XJ 3-YL]BUTANAMIDE FORMUL 3 NA NA 1+ FORMUL 4 6XJ 2(C33 H36 BR CL2 N5 O4) FORMUL 6 HOH *87(H2 O) HELIX 1 AA1 ASP A 172 GLY A 192 1 21 HELIX 2 AA2 ALA A 202 HIS A 224 1 23 HELIX 3 AA3 HIS A 224 ASP A 236 1 13 HELIX 4 AA4 ASN A 239 SER A 245 1 7 HELIX 5 AA5 LEU A 246 ILE A 251 1 6 HELIX 6 AA6 HIS A 252 PHE A 254 5 3 HELIX 7 AA7 ASN A 260 ILE A 281 1 22 HELIX 8 AA8 GLN A 283 SER A 285 5 3 HELIX 9 AA9 CYS A 286 GLN A 309 1 24 HELIX 10 AB1 ARG A 310 PHE A 319 1 10 HELIX 11 AB2 LEU B 174 GLY B 192 1 19 HELIX 12 AB3 ARG B 208 HIS B 224 1 17 HELIX 13 AB4 HIS B 224 LEU B 235 1 12 HELIX 14 AB5 ASN B 239 SER B 245 1 7 HELIX 15 AB6 LEU B 246 ILE B 251 1 6 HELIX 16 AB7 HIS B 252 PHE B 254 5 3 HELIX 17 AB8 ASN B 260 ILE B 281 1 22 HELIX 18 AB9 GLN B 283 SER B 285 5 3 HELIX 19 AC1 CYS B 286 LYS B 302 1 17 HELIX 20 AC2 LYS B 302 GLN B 309 1 8 HELIX 21 AC3 TRP B 312 PHE B 319 1 8 LINK OE1 GLU A 240 NA NA A 401 1555 1555 2.86 LINK OE1 GLN A 283 NA NA A 401 1555 2555 3.19 LINK OG SER A 285 NA NA A 401 1555 2555 2.81 LINK NA NA A 401 O HOH A 542 1555 2555 2.30 SITE 1 AC1 5 GLU A 240 ASN A 282 GLN A 283 SER A 285 SITE 2 AC1 5 HOH A 542 SITE 1 AC2 17 HIS A 224 MET A 231 VAL A 249 MET A 250 SITE 2 AC2 17 HIS A 252 VAL A 253 SER A 255 ASP A 256 SITE 3 AC2 17 ARG A 263 THR A 266 PHE A 270 ARG A 310 SITE 4 AC2 17 GLU A 317 HOH A 505 HOH A 516 HOH A 528 SITE 5 AC2 17 HOH A 535 SITE 1 AC3 7 ARG A 176 HIS B 224 MET B 231 HIS B 252 SITE 2 AC3 7 VAL B 253 ARG B 263 PHE B 270 CRYST1 84.381 60.647 69.087 90.00 121.15 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011851 0.000000 0.007163 0.00000 SCALE2 0.000000 0.016489 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016913 0.00000